Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Entyvio
Entyvio
Lilly inks $3.2B Morphic buyout to snag oral rival to Takeda's IBD blockbuster
Fierce Biotech
Mon, 07/8/24 - 11:54 am
Eli Lilly
Morphic
M&A
Takeda
Entyvio
IBD
Takeda’s Entyvio receives FDA approval for subcutaneous administration
Pharmaceutical Technology
Thu, 09/28/23 - 11:46 pm
Takeda
Entyvio
ulcerative colitis
FDA
Takeda tries again with subcutaneous Entyvio
Pharmaphorum
Fri, 04/28/23 - 10:02 am
Takeda
Entyvio
ulcerative colitis
Not IDEAL: Protagonist sinks as high dose of oral Entyvio rival fails in ulcerative colitis
Fierce Biotech
Tue, 04/26/22 - 10:16 am
Protagonist Therapeutics
clinical trials
ulcerative colitis
Entyvio
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
Mon, 07/12/21 - 11:08 am
patents
patent cliff
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Revlimid
Pfizer
Eliquis
Regeneron
Eylea
JNJ
Stelara
Opdivo
GSK
Dolutegravir
Ibrance
Januvia
Eli Lilly
Trulicity
Novo Nordisk
Victoza
Amgen
Prolia
Xgeva
Novartis
Cosentyx
Takeda
Entyvio
Early Morphic data hint at a threat to Entyvio
EP Vantage
Mon, 03/1/21 - 11:47 pm
Morphic Therpeuitc
Entyvio
MORF--57
Takeda
Roche’s test of novel gut target nears
EP Vantage
Tue, 05/12/20 - 11:39 am
Roche
ulcerative colitis
etrolizumab
Takeda
Entyvio
Takeda’s Entyvio Ad Captures Struggle to Make Plans
Xtalks
Mon, 05/6/19 - 10:52 am
Takeda
DTC ads
inflammatory bowel disease
Entyvio
Takeda’s Entyvio Bests Humira in Head-to-Head UC Study
BioSpace
Mon, 03/11/19 - 10:25 am
Takeda
Entyvio
AbbVie
Humira
ulcerative colitis
Takeda Drug Achieves Primary Endpoint of Clinical Remission in Moderately to Severely Active Ulcerative Colitis
CP Wire
Thu, 07/19/18 - 11:20 am
Takeda
vedolizumab
ulcerative colitis
Entyvio
Takeda Drug Achieves Primary Endpoint of Clinical Remission in Moderately to Severely Active Ulcerative Colitis
Thu, 07/19/18 - 10:07 am
Takeda
Entyvio
ulcerative colitis
Chron's Disease
Takeda pursuing needle-free delivery for its top-selling biologic
BioPharma Dive
Wed, 11/8/17 - 06:25 pm
Takeda
needle free delivery
Portal Instruments
devices
Entyvio
A drug used to treat Crohn’s disease could suppress HIV, monkey study suggests
Stat
Fri, 10/14/16 - 11:42 am
Crohn’s disease
HIV
vedolizumab
Entyvio
Takeda
Takeda Acquires U.S. Biologics Manufacturing Facility
Yahoo
Tue, 01/5/16 - 09:26 pm
Takeda
drug manufacturing
Entyvio
Takeda’s Bowel Disease Drug Approved by U.S. Regulators
Bloomberg
Wed, 05/21/14 - 10:26 am
Takeda
FDA
Entyvio
vedolizumab
ulcerative colitis
Crohn's Disease
Takeda gets positive CHMP opinion for Entyvio for UC and Crohn’s disease
The Pharma Letter
Sat, 03/22/14 - 12:46 pm
Takeda
vedolizumab
Entyvio
ulcerative colitis
Crohn's Disease